: An Experimental, One-Time Gene Therapy for Parkinson’s Disease If your response to Parkinson’s disease medications has...see more
Research Updates
In September, APDA announced funding for cutting-edge research projects for the 2019-2020 academic year totaling $1.7 million....see more
APDA GATHERS WITH GLOBAL PD COMMUNITY
2019 World Parkinson Congress Highlights: A world away, but so close together No matter where we find ourselves –...see more
Coloring outside the lines of traditional PD therapies
New Program Offers Creative Outlet, Improves PD Symptoms An innovative new...see more
Creating Connections
Beyond the Doctor’s Visit: Taking Parkinson’s Care to the Next Level “Game changing.” That’s how Robin...see more
Taking Parkinson’s education to the farmers market: educating under-served communities
Dr. Lynda Nwabuobi, Movement Disorder Fellow at Columbia Presbyterian...see more
THE AMERICAN PARKINSON DISEASE ASSOCIATION AWARDS FRESH CROP OF RESEARCH GRANTS & NEW DIVERSITY-FOCUSED RESEARCH INITIATIVE
The American Parkinson Disease Association Awards Fresh Crop of Research Grants & New Diversity-Focused Research Initiative From T cells...see more
APDA DIVERSITY IN PD RESEARCH GRANT: ACADEMIC YEAR 2022-2023
Deadline: 03/11/2022 APPLY HERE Award details One year grant up to a maximum of $75,000 will be awarded to...see more
New medication, Istradefylline, gets approved for Parkinson’s disease
On August 27, 2019, pharmaceutical company Kyowa Kirin received FDA approval...see more
APDA Seed Funding Leads to Prestigious NIH Research Grant
APDA is exceptionally proud to congratulate Dr. Beom-Chan Lee, APDA Research...see more